{
    "Case ID": "030098",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "infringement_analysis": [
                "drospirenone in molecular dispersion form",
                "falls under the patent claims"
            ],
            "relevant_rule": [
                "Patent claims must be construed to determine infringement"
            ],
            "evidence_presented": [
                "Apotex's product used molecular dispersion form",
                "avoiding infringement"
            ],
            "decision_reasoning": [
                "drospirenone in a molecular dispersion form does not fall within the claims of the '426 Patent as construed"
            ],
            "result_of_case": [
                "Application dismissed due to justified non-infringement allegations by Apotex"
            ],
            "cause_of_action": [
                "Bayer sought to prohibit Apotex from obtaining regulatory approval for its generic version of YAZ tablets until the '426 Patent expired"
            ],
            "procedure_followed": [
                "Court analyzed patent claims, evidence of Apotex's formulation process, and legal principles governing infringement and validity"
            ]
        }
    ]
}